Rajarambapu College Of Pharmacy, Kasegaon.
This study focuses on the synthesis and evaluation of 2-chloromethyl-1H-benzimidazole derivatives for potential pharmacological applications. Subsequent reactions with various nucleophiles, including amines, alcohols, and thiols, afforded a library of diverse benzimidazole derivatives. The synthesized compounds were characterized using spectroscopic techniques such as, infrared (IR) spectroscopy. The purity and structural integrity of the compounds were confirmed, ensuring reliable results for subsequent evaluations. Biological evaluation of the synthesized derivatives was conducted to assess their potential pharmacological activities. Antimicrobial assays against a panel of bacterial strains were performed to determine the compounds' efficacy in inhibiting microbial growth. Overall, the synthesis and evaluation of 2-chloromethyl-1H-benzimidazole derivatives represent a promising approach for the discovery of novel pharmacologically active compounds with potential applications in antimicrobial and anticancer drug development. Further studies are warranted to explore the therapeutic potential of these derivatives and their mechanism of action in relevant biological systems.
For the healthcare professional, invasive bacterial infections pose significant diagnostic and treatment hurdles. Even with the widespread use of topical antibacterial medications, systemic and superficial bacterial infections continue to be major sources of morbidity and mortality among transplant recipients, despite the fact that many viral infections are now preventable. Furthermore, as a result of bacterial resistance, antibacterial medications used to treat bacterial infections are now less effective. The objective of present study was to synthesize novel 2-chloromethyl-1H- benzimidazole derivatives by using different aromatic amines and heterocycle and to evaluate them for antimicrobial activity. In recent years, considerable attention has been given to the synthesis of benzimidazole derivatives because of their various pharmacological activities such as antitumour, anti-ulcer, anti-inflammatory, antiviral, anthelmintic, antibacterial and antifungal properties.
Investigating the antifungal activity of 2-chloromethyl-1H-benzimidazole derivatives is important for several reasons:
Plan of Work:
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-12.png" target="_blank">
<img alt="Plan of Work.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-12.png" width="150">
</a>
Objective:
Chemicals used are-
Chloroacetic acid and O-Phenylenediamine, Aniline, p-nitro aniline, p-amino phenol, p-amino benzoic acid, sulphanilamide, Potassium Carbonate (K2CO3), Dimethylformamide (DMF), Potassium Iodide(KI), Ethyl Acetate, Sodium Sulphate was purchased from S.D. Chemical Lab, Mumbai.
2-chloromethyl-1H-benzimidazole derivatives were prepared by condensing 2-chloromethyl-1H- benzimidazole with different aromatic amines and heterocycle. The synthesized were screened for their antimicrobial activity against Staphylococcus aureus (Gram-positive Bacteria) by well plate method.
Synthesis of 2-Chloromethyl-1H-benzimidazole (As starting material)
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-11.png" target="_blank">
<img alt="1.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-11.png" width="150">
</a>
Procedure:
Applications: 2-Chloromethyl-1H-benzimidazole and its derivatives have several applications and uses across various fields, primarily due to their diverse chemical properties and pharmacological activities. Some common applications include:
Spectral Data:
Yield:60%; melting point:153- 155°C; TLC: Chloroform: Methanol (9:1); Rf: 0.68 IR (Infrared) Interpretation:
Sr. No. |
Functional Group |
Standard Range |
Observed Values |
1 |
N-H |
3500-1000 |
3386.39 |
2 |
C-H Aromatic |
3150-3050 |
3029.62 |
3 |
C=N |
1690-1640 |
1637.27 |
4 |
C=C |
1600-1475 |
1594.35 |
5 |
C-Cl |
785-540 |
750.17 |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-10.png" target="_blank">
<img alt="2.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-10.png" width="150">
</a>
Synthesis of 2-Chloromethyl 1H-benzimidazole derivatives
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-9.png" target="_blank">
<img alt="3.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-9.png" width="150">
</a>
Procedure:
Spectral Data:
Yield: 70%, melting point: 146-148°C TLC: Benzene: Ethyl acetate (4:1), Rf: 0.43
IR (Infrared) Interpretation
Sr. No. |
Functional group |
Standard range |
Observed values |
1 |
N-H |
3500-3100 |
3154.97 |
2 |
C=C |
1680-1550 |
1577.49 |
3 |
C-N |
1350-1000 |
1272.79 |
4 |
Aromatic C-H |
900-690 |
750.17 |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-8.png" target="_blank">
<img alt="4.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-8.png" width="150">
</a>
Synthesis of (1H-Benzimidazole-2-ylmethyl) -(4-nitro-phenyl)-amine
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-7.png" target="_blank">
<img alt="5.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-7.png" width="150">
</a>
Procedure:
Spectral Data:
IR (Infrared) Interpretation
Sr. No. |
Functional group |
Standard range |
Observed values |
1 |
N-H |
3500-3100 |
3361.32 |
2 |
C-H |
3000-2850 |
2927.41 |
3 |
N=O |
1600-1350 |
1589.06 |
4 |
C-N |
1350-1000 |
1301.72 |
5 |
C-O |
1300-1000 |
1112.73 |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-6.png" target="_blank">
<img alt="6.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-6.png" width="150">
</a>
Synthesis of 4-((1H-benzimidazol-2-ylmethyl)amino)benzoic acid
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-5.png" target="_blank">
<img alt="7.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-5.png" width="150">
</a>
Procedure:
Spectral Data:
IR (Infrared) Interpretation
Sr. No. |
Functional group |
Standard range |
Observed values |
1 |
N-H |
3500-3100 |
3336.25 |
2 |
O-H |
3400-2400 |
3212.83 |
3 |
C-H |
2950-2800 |
2929.34 |
4 |
C=C |
1680-1600 |
1658.48 |
5 |
C-N |
1350-1000 |
1267.00 |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-4.png" target="_blank">
<img alt="8.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-4.png" width="150">
</a>
Synthesis of (1H-Benzimidazole-2-ylmethyl) -(4-hydroxy-phenyl)-amine
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-3.png" target="_blank">
<img alt="9.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-3.png" width="150">
</a>
Procedure:
Spectral Data:
IR (Infrared) Interpretation:
Sr. No. |
Functional group |
Standard range |
Observed values |
1 |
N-H |
3500-3100 |
3386.39 |
2 |
C=O |
1680-1600 |
1631.48 |
3 |
C-N |
1350-1000 |
1278.57 |
4 |
C-O |
1300-1000 |
1012.45 |
5 |
Aromatic C-H |
900-690 |
827.31 |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-2.png" target="_blank">
<img alt="10.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-2.png" width="150">
</a>
Synthesis of 4[(1H-Benzimidazole-2-ylmethyl)-amino]-benzene sulfonamide
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-1.png" target="_blank">
<img alt="11.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-1.png" width="150">
</a>
Procedure:
Spectral Data:
IR (Infrared) Interpretation:
Sr. No. |
Functional group |
Standard range |
Observed values |
1 |
N-H |
3600-3100 |
3172.33 |
2 |
C=O |
1680-1600 |
1629.33 |
3 |
C=C |
1680-1550 |
1594.84 |
4 |
S=O |
1375-1300 |
1307.50 |
5 |
Aromatic C-H |
900-690 |
827.31 |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-0.png" target="_blank">
<img alt="12.png" height="150" src="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606122401-0.png" width="150">
</a>
Antimicrobial Study
Microbiology is one of the basic sciences it attempts to cover most of its offshoots such as bacteriology, and immunology, virology and mycology have already established themselves as separate and independent sciences. microorganism are closely associated with the health and welfare of human beings; some microorganisms are beneficial and other are detrimental. Bacteria and yeast were actually first observed under the microscope in the 18" century, and in 1877 Pasteur and Joubert reported how a culture could be inhibited by products of a contaminating organism. The most celebrated of these observations is Fleming's who in 1929 observed the lysis of staphylococci colonies adjacent to colonies of the mold Penicillium notatum.53 Waksman, a soil microbiologist in 1944, discovered streptomycin. The first synthetic compounds were sulfonamide, and amino benzene sulfonamide, were characterized in mid 1930s by Trefoil in France. Antibiotics are microbial metabolites or synthetic analogues inspired by them that, in small doses, inhibit the growth and survival of microorganisms without serious toxicity to the host. Selective toxicity is the key concept. Antibiotics are among the most frequently prescribed medications today, although microbial resistance result in from evolutionary pressures and misuse threatens their continued efficacy. In many cases, the clinical utility of natural antibiotics has been enhanced through medicinal chemical manipulation of the original structure, leading to broader antimicrobial spectrum, greater potency, lesser toxicity, more convenient administration and additional pharmacokinetic advantages. Through customary usage, the many synthetic substances that are unrelated to natural products but still inhibit or kill microorganisms are referred to as antimicrobial agents instead. Because of a significant decrease in the pace of novel ant infective discovery, increased regulatory constraints, and greater profits to be made by the use of medications for chronic conditions, there is presently a decreased research emphasis on microbial agents. This coincides with a dramatic increase in microbial resistance to chemotherapy that portends a bleak future in which humankind may once again face infectious diseases with few available countermeasures. Our environment, body surfaces, and cavities support a rich and character stick microbial flora. These cause us no significant illness or inconvenience as long as our neighbours or we do not indulge in behaviour that exposes us to exceptional quantities or unusual strains of microbes or introduces bacterial into parts of the body where they are not normally resident. Protect ion against this happening is obtained primarily through public health measures, heal the full habits, intact skin and mucosal barriers. and a properly functioning immune system. All parts of our bodies that are in contact with the environment support microbial life. It is estimated that I g of feces contains approximately 1013 microorganisms! All our internal fluids, organs, and body structures, however, are sterile under normal circumstances, and the presence of bacteria, fungi, viruses, or other organisms in these places is diagnostic evidence of infection. When mild microbial disease occurs, the otherwise healthy patient often will recover without requiring treatment. Here, an intact, functioning immune system is called on to kill invasive microorganisms. When this is insufficient to protect us, appropriate therapeutic intervention is indicated.
Clinical Significance:
The treatment of bacterial infections is one of the few disease states that all clinicians are guaranteed to be challenged with at some time in their career. Because bacteria are constantly changing, the selection of appropriate antimicrobial therapy is crucial in providing efficacious treatment of infect ions. It is of the utmost importance that clinicians understand the medicinal chemistry of antimicrobial agents to choose the most effective therapy for their patients.
Antibacterial Activity
Method For Antibacterial Activity Determination:
Dilution of the compounds:
All the synthesized compounds were dissolved in DMSO (Dimethyl Sulfoxide) so as to get concentration of 50μg/ml and 100μg/ml and standard drugs Ciprofloxacin as a concentration of 10mg/ml.
Sterilization of equipment’s
Sterilisation is the complete destruction of all microorganisms by suitable chemical agent or by heat in Hot air oven under pressure at 100-120°C for at least 15 minutes
Selection of microorganisms:
Choose a panel of microorganisms against which you want to test the antimicrobial activity. This may include bacteria (both Gram-positive and Gram-negative), and other pathogens. The staphylococcus aureus bacteria Was selected. Staphylococcus aureus is gram-positive type bacteria which is found in upper respiratory tract and on skin.
Chemicals
Nutrient agar medium [NO11], and normal saline solution were sterilized in autoclave at 15 lbs pressure [121C] for 15 minutes. Petri plates, Whatman filter paper and cotton swabs were sterilized in oven at 100-120°C for at least 15 minutes
Preparation of Nutrient agar:
Nutrient Agar (Peptone, Beef extract, Sodium chloride, Agar and distilled water were used) boiled and poured in test tube then plugged with cotton and sterilized in autoclave at 15lbs pressure (1210C) for 15 min. After sterilization the tubes containing the Nutrient agar were poured in petri plate and kept for 30 min. Then on the surface of plates pure culture staphylococcus aureus were streaked in aseptic condition and cooled. After cooling the solution whose antibacterial activity is to be check is inserted in plate and the plates are incubated at 37°C for 24 hrs.
Measurement of Inhibition zones:
Measure the diameter of the zones of inhibition around the disks after a specified incubation period. Larger zones indicate greater antimicrobial activity
Comparison with Standard Drugs:
Compare the antimicrobial activity of the compound with that of standard antimicrobial drugs to assess its efficacy and potential for further development.
Sample |
Front view |
Back view |
Standard sample (Ciprofloxacin) |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-17.jpg" target="_blank"> |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-16.jpg" target="_blank"> |
(1H-Benzimidazole-2- ylmethyl)-phenyl amine |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-15.jpg" target="_blank"> |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-14.jpg" target="_blank"> |
(1H-Benzimidazole-2-ylmethyl) (4-nitro-phenyl)-amine |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-13.jpg" target="_blank"> |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-12.jpg" target="_blank"> |
4-((1H-benzimidazol-2- ylmethyl)amino)benzoic acid |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-11.jpg" target="_blank"> |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-10.jpg" target="_blank"> |
1H-Benzimidazole-2-ylmethyl)- (4-hydroxy-phenyl)-amine |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-9.jpg" target="_blank"> |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-8.jpg" target="_blank"> |
4[(1H-Benzimidazole-2- ylmethyl)-amino]- benzenesulfonamide |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-7.jpg" target="_blank"> |
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-6.jpg" target="_blank"> |
Observation:
Five derivatives of 2-Chloromethyl-1H-benzimidazole were synthesized using different aromatic amines and heterocycles as substituents. Synthesized compounds were characterized by chromatographic methods, Infrared spectroscopy for their structural confirmation. These five compounds were tested for antifungal activity by in vitro well plate method. Activity was presented in the form of zone of inhibition (mm) in agar culture plates are seen as below.
Compound |
Zone of inhibition |
|
50μg/ml |
100μg/ml |
|
Standard sample |
2.7 |
3.3 |
(1H-Benzimidazole-2- ylmethyl)-phenyl amine |
1.3 |
1.6 |
(1H-Benzimidazole-2- ylmethyl)-(4-nitro-phenyl)- amine |
2.0 |
2.4 |
4-((1H-benzimidazol-2- ylmethyl)amino)benzoic acid |
1.6 |
1.9 |
1H-Benzimidazole-2- ylmethyl)-(4-hydroxy-phenyl)- amine |
1.4 |
1.6 |
4[(1H-Benzimidazole-2- ylmethyl)-amino]- benzenesulfonamide |
2.1 |
3.2 |
4[(1H-Benzimidazole-2-ylmethyl)-amino]-benzenesulfonamide exhibited maximum activity among the Five Derivatives of 2-Chloromethyl-1H-benzimidazole with MIC (Minimum Inhibitory Concentration) equal to that of the Standard Ciprofloxacin.
RESULTS & DISCUSSION
Compounds & Structure |
Molecular Formula |
Practical Yield |
Melting point |
Rf value |
Zone of inhibition |
|
|
50μg/ml |
100 μg/ml |
|
|||||
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-5.jpg" target="_blank"> |
C8H8CIN2 |
60% |
153-155°C |
0.43 |
2.7 |
3.3 |
|
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-4.jpg" target="_blank"> |
C14H13N3 |
70% |
146-148°C |
0.47 |
1.3 |
1.6 |
|
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-3.jpg" target="_blank"> |
C13H10N4 02 |
46% |
118-120°C |
0.66 |
2.0 |
2.4 |
|
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-2.jpg" target="_blank"> |
C15H13N3 O2 |
48% |
120-152°C |
0.60 |
1.6 |
1.9 |
|
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-1.jpg" target="_blank"> |
C14H12N2 0 |
62% |
170-172°C |
0.54 |
1.4 |
1.6 |
|
<a href="https://www.ijpsjournal.com/uploads/createUrl/createUrl-20250606123157-0.jpg" target="_blank"> |
C13H14N4 02S |
48% |
196-198°C |
0.63 |
2.1 |
3.2 |
|
Five derivatives of 2-Chloromethyl-1H-benzimidazole were synthesized using different aromatic amines and heterocycles as substituents. Synthesized compounds were characterized by chromatographic methods and Infrared spectroscopy for their structural confirmation. These five compounds were tested for antimicrobial activity by in vitro well plate method. Activity was presented in the form of zone of inhibition (mm) in agar culture plates and MIC.
CONCLUSION
In conclusion, the synthesis and evaluation of 2-chloromethyI-1H-benzimidazole derivatives have provided valuable insights into their potential as novel antimicrobial agents. Further research and development efforts are necessary to optimise their therapeutic utility and advance them towards clinical application.
REFERENCES
Aniket Gadale*, Disha Fartade, Synthesis and Antimicrobial Evaluation of 2-chloromethyl-1H- benzimidazole Derivative, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 1111-1128. https://doi.org/10.5281/zenodo.15606176